Written & medically reviewed by Dr. Sanjay Anbu, MBBS· Last reviewed
Linagliptin is a DPP-4 inhibitor that needs no dose change in kidney disease. It belongs to the Oral diabetes medicine (extra) group. More tablets that control blood sugar in type 2 diabetes by different routes.
Rare serious ketoacidosis with SGLT2 (unusual symptoms — seek care)
Not a prescription — no dose shown. The right dose of linagliptin depends on age, weight, kidney/liver function and the condition, so MedDroid does not show a dose here. Always get your dose from a doctor or pharmacist and the leaflet inside the pack. General educational information only.
Frequently asked questions
What are “gliptins” and “gliflozins”?
Gliptins (DPP-4 inhibitors, like linagliptin) gently improve insulin response; gliflozins (SGLT2 inhibitors, like canagliflozin) remove sugar via the urine and help the heart/kidneys.
Which diabetes tablet suits kidney disease?
Linagliptin needs no dose change in kidney disease, and some SGLT2 inhibitors protect the kidneys — your doctor chooses based on your kidney function.
Reviewed by Dr. Sanjay Anbu, MBBS. MedDroid is an AI medical assistant and can make mistakes. It provides general health information, not a diagnosis or medical advice — always consult a qualified clinician. In an emergency, contact your local emergency number immediately.